RE: Market Cap7 May 2020 18:16
Not sure why people like to look at the revenue to mcap angle, it's completely redundant in this industry .... early stage bio/pharma's are almost always about forward earnings potential - the majority either failing or being bought out before anything material is realised
You should probably watch the presentation, the number of different product pipelines with references to markets/similar deals in the billion $ range clearly demonstrates that the potential is far from being priced in
As for why no one was interested at 20p.... sometimes you just need a spotlight to unearth a goldmine, as with 95% of AIM
IMO